A former Pharmaceutical Society president turned medicinal cannabis entrepreneur is calling for ACC and the Ministry of Social Development to form coherent policies on funding of prescribed medicinal cannabis products.
A former Pharmaceutical Society president turned medicinal cannabis entrepreneur is calling for ACC and the Ministry of Social Development to form coherent policies on funding of prescribed medicinal cannabis products.
New Zealand’s over 3,500 practising pharmacists need to urgently familiarise themselves with medicinal cannabis. Patient enquiries and demand are set to surge when Kiwi-made products come onto the market later this year, says one pharmacist who should know.
New Zealand’s largest licenced medicinal cannabis company,Helius Therapeutics, has been issued with the industry’s first GMP (Good Manufacturing Practice) Licence to Manufacture Medicines by MedSafe. It allows the company to begin manufacturing locally made medicines for New Zealand patients.
An Auckland medicinal cannabis clinic is being investigated for breaching supply and advertising rules, while the activities of other suppliers are also causing concern for the New Zealand Medical Cannabis Council
The new Medicinal Cannabis Scheme is being undermined with a significant volume of unregulated imports of unknown quality and consistency readily available, according to industry representatives
Results from the cannabis referendum showed that, as a nation, we are not ready to legalise cannabis. However, patients with a variety of problems ask to be prescribed medicinal cannabis. Psychiatrist David Codyre, reviews the evidence for both benefits and harms of cannabinoids
Medicinal cannabis industry leader Manu Caddie says claims reported from a recent medicinal cannabis conference that there was no new evidence revealed in the conference’s medical sessions are incorrect